Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells-Reference-Cited by-同舟云学术

Nuclear factor-ĸB plays a critical role in both intrinsic and acquired resistance against endocrine therapy in human breast cancer cells

Published:2014-02-17 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Oida Kumiko,Matsuda Akira,Jung Kyungsook,Xia Yan,Jang Hyosun,Amagai Yosuke,Ahn Ginnae,Nishikawa Sho,Ishizaka Saori,Jensen-Jarolim Erika,Matsuda Hiroshi,Tanaka Akane

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep04057.pdf

Reference41 articles.

1. Harvey, J. M., Clark, G. M., Osborne, C. K. & Allred, D. C. Estrogen receptor status by endocrine therapy in breast cancer. J. Clin. Oncol. 17, 1474–1481 (1999).

2. Jensen, E. V. On the mechanism of estrogen action. Perspect. Biol. Med. 6, 47–54 (1962).

3. Kuiper, G. G. et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. USA 93, 5925–5930 (1996).

4. Hamis, L. et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J. Clin. Oncol. 25, 5287–5312 (2007).

5. Hammond, M. E. et al. American Society of Clinical Oncology/College of American pathogenesis guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J. Clin. Oncol. 28, 2784–2795 (2010).

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of EGFR and FASN in breast cancer progression;Journal of Cell Communication and Signaling;2023-07-25

2. Modulating multidrug resistance to drug-based antitumor therapies through NF-κB signaling pathway: mechanisms and perspectives;Expert Opinion on Therapeutic Targets;2023-06-03

3. MAP3K1 expression is associated with progression and poor prognosis of hormone receptor-positive, HER2-negative early-stage breast cancer;Cellular Oncology;2023-05-11

4. Potential therapeutic role for pigment epithelium-derived factor in post-menopausal breast cancer bone metastasis;Journal of Pharmacy and Pharmacology;2023-04-28

5. Inflammasomes in breast cancer: the ignition spark of progression and resistance?;Expert Reviews in Molecular Medicine;2023